PatientsVille.com Logo

PatientsVille

Olopatadine Side Effects

Common Olopatadine Side Effects

The most commonly reported Olopatadine side effects (click to view or check a box to report):

Hepatic Function Abnormal (3)
Aspartate Aminotransferase Increased (3)
Circulatory Collapse (2)
Alanine Aminotransferase Increased (2)
Haematocrit Increased (2)
Dizziness (2)
Pyrexia (2)
Arrhythmia (2)
White Blood Cell Count Increased (2)
Blood Pressure Decreased (2)
Cardiac Arrest (2)
Malaise (2)
Bradycardia (2)
Blood Creatinine Increased (2)
Arthralgia (1)
Apraxia (1)
Asthenia (1)
Constipation (1)
Psychotic Disorder (1)
Autonomic Neuropathy (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Olopatadine Side Effects Reported to FDA

The following Olopatadine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Olopatadine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anosmia
on Oct 16, 2012 Female from US , 56 years of age, weighting 140.0 lb, was diagnosed with and was treated with Olopatadine. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: anosmia. Olopatadine dosage: 2 Spray In Each Postril.

Renal Impairment
Patient was taking Olopatadine Hcl. Patient felt the following Olopatadine side effects: renal impairment on Jun 06, 2012 from JAPAN Additional patient health information: Male , 42 years of age, . Olopatadine Hcl dosage: Unk.
Multiple prescriptions taken:
  • Lipitor
  • Diovan (Unk)
  • Allegra (Unk)


Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased
Adverse event was reported on May 08, 2012 by a Male taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 78 years of age, After Olopatadine was administered, patient encountered several Olopatadine side effects: blood potassium increased, renal disorder, haemoglobin decreased, acute respiratory failure, blood creatinine increased, haematocrit decreased, blood alkaline phosphatase increased, blood urea increased.
Multiple concurrent drugs taken:
  • Lansoprazole
  • Loxonin
  • Glufast
  • Antebate
  • Prednisolone
  • Prednisolone
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)


Toxic Skin Eruption
on May 17, 2012 Female from JAPAN , 69 years of age, weighting 88.18 lb, was treated with Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: toxic skin eruption. Olopatadine Hcl dosage: N/A.
Associated medications used:
  • Galantamine Hydrobromide
  • Aspirin Dialuminate
  • Norvasc



Aggression, Suicide Attempt
on Apr 23, 2012 Female from JAPAN , 39 years of age, was diagnosed with and was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: aggression, suicide attempt. Olopatadine Hcl dosage: Unk.
Multiple prescriptions taken:
  • Litiomal
  • Clonazepam
  • Goodmin
  • Yaz (1 Df, Qd)
  • Eticalm


Juvenile Arthritis, Hepatic Function Abnormal
Patient was taking Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: juvenile arthritis, hepatic function abnormal on Apr 27, 2012 from JAPAN Additional patient health information: Female , weighting 103.6 lb, was diagnosed with and. Olopatadine Hcl dosage: N/A.
Multiple concurrent drugs taken:
  • Methotrexate
  • Folic Acid
  • Prednisolone
  • Methotrexate
  • Adalimumab
  • Lansoprazole
  • Adalimumab
  • Prednisolone (15-30 Mg/day)
Patient was hospitalized.

Haematocrit Increased, Leukocytosis, Chronic Myeloid Leukaemia
Adverse event was reported on Jan 30, 2012 by a Male taking Olopatadine Hcl (Dosage: 10mg Per Day) was diagnosed with and. Location: JAPAN , weighting 211.6 lb, Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: haematocrit increased, leukocytosis, chronic myeloid leukaemia.
Associated medications used:
  • Rabeprazole Sodium (10mg Per Day)
  • Torsemide (8mg Per Day)
  • Lisinopril (10mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Allopurinol (100mg Per Day)
  • Flolan


Loss Of Consciousness, Nausea, Vomiting
on Jan 30, 2012 Female from JAPAN , 69 years of age, was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: loss of consciousness, nausea, vomiting. Olopatadine Hcl dosage: 10 Mg, 1x/day.
Multiple prescriptions taken:
  • Lyrica (50 Mg, 2x/day)
  • Mucodyne (1000 Mg, 1x/day)
  • Cleanal (400 Mg, 1x/day)
Patient was hospitalized.

Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation
on Jan 20, 2012 Male from JAPAN , 54 years of age, weighting 138.9 lb, was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: hepatic neoplasm malignant, pyrexia, neutrophil count increased, hepatic function abnormal, insomnia, hypertension, constipation. Olopatadine Hcl dosage: Daily Dose 10 Mg.
Multiple concurrent drugs taken:
  • Atarax (Daily Dose 50 Mg)
  • Nexavar (400 Mg, Qd)
  • Lansoprazole (Daily Dose 15 Mg)
  • Hirudoid (Unk)


Blood Glucose Increased
Patient was taking Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: blood glucose increased on Dec 27, 2011 from JAPAN Additional patient health information: Male , 73 years of age, weighting 154.3 lb, . Olopatadine Hcl dosage: N/A.
Associated medications used:
  • Antithrombotic Agents
  • Coniel
  • Plavix
  • Anplag
  • Aspirin
  • Basen
  • Anplag
  • Tricor
Patient was hospitalized.

Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio Decreased
Adverse event was reported on Dec 20, 2011 by a Female taking Olopatadine Hcl (Dosage: N/A) was diagnosed with and. Location: JAPAN , 81 years of age, Patient felt the following Olopatadine side effects: blood albumin decreased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, epstein-barr virus antibody positive, faeces pale, allergic hepatitis, prothrombin time prolonged, malaise, prothrombin time ratio decreased.
Multiple prescriptions taken:
  • Atarax
  • Xyzal
  • Celestamine Tab
Patient was hospitalized.

Laceration
on Dec 13, 2011 Female from JAPAN , 71 years of age, was diagnosed with and was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: laceration. Olopatadine Hcl dosage: 5 Mg, 2x/day.
Multiple concurrent drugs taken:
  • Hirudoid (Unk)
  • Drenison (Unk)
  • Lipitor (10 Mg, Uid/qd)


Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic
on Nov 04, 2011 Female from UNITED STATES , 25 years of age, weighting 135.0 lb, was treated with Olopatadine Hydrochloride. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: pain, myocardial infarction, cerebrovascular accident, pulmonary embolism, anxiety, gallbladder disorder, deep vein thrombosis, cholecystitis acute, cholecystitis chronic. Olopatadine Hydrochloride dosage: Unk Unk, Prn.
Associated medications used:
  • Xanax (Unk)
  • Drospirenone And Ethinyl Estradiol (Unk)
  • Prednisone (Unk)
  • Pepcid (Unk Unk, Qd)
  • Yasmin (Unk)
  • Advair Diskus 100/50 (Unk)
  • Allegra
  • Flonase


Dyspnoea, Burning Sensation
Patient was taking Olopatadine Hydrochloride. Patient felt the following Olopatadine side effects: dyspnoea, burning sensation on Oct 19, 2011 from UNITED STATES Additional patient health information: Male , weighting 195.2 lb, was diagnosed with and. Olopatadine Hydrochloride dosage: N/A.
Multiple prescriptions taken:
  • Fluticasone Propionate
  • Proair Hfa


Pulmonary Artery Thrombosis, Venous Thrombosis
Adverse event was reported on Oct 12, 2011 by a Female taking Olopatadine Hcl (Dosage: 1 Tablet, As Needed) was diagnosed with and. Location: JAPAN , 29 years of age, weighting 132.3 lb, After Olopatadine was administered, patient encountered several Olopatadine side effects: pulmonary artery thrombosis, venous thrombosis.
Multiple concurrent drugs taken:
  • Crizotinib (250 Mg, 2x/day)
  • Milmag (2 Tablets, As Needed)
  • Kindavate (As Needed)
Patient was hospitalized.

Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, Trismus
on Oct 03, 2011 Male from JAPAN , 75 years of age, was treated with Olopatadine Hcl. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: jaw disorder, paralysis, viith nerve paralysis, apraxia, tenderness, cranial nerve palsies multiple, temporomandibular joint syndrome, dysphagia, trismus. Olopatadine Hcl dosage: N/A.
Associated medications used:
  • Mucosta
  • Cefazolin Sodium (Dosage Form: Powder)
  • Methaderm
  • Ferrum
  • Xyzal
  • Tranexamic Acid
  • Xyzal
  • Bio-three
Patient was hospitalized and became disabled.

Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal
on Oct 04, 2011 Male from JAPAN , 71 years of age, weighting 160.9 lb, was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: aspartate aminotransferase increased, alanine aminotransferase increased, hepatic function abnormal. Olopatadine Hcl dosage: N/A.
Multiple prescriptions taken:
  • Allopurinol
  • Arava
  • Uralyt
  • Azulfidine
  • Flivas
  • S. Adchnon
  • Comelian
Patient was hospitalized.

White Blood Cell Count Increased, Haematocrit Increased
Patient was taking Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: white blood cell count increased, haematocrit increased on Sep 29, 2011 from JAPAN Additional patient health information: Male , weighting 211.6 lb, was diagnosed with and. Olopatadine Hcl dosage: 10mg Per Day.
Multiple concurrent drugs taken:
  • Flolan
  • Allopurinol (100mg Per Day)
  • Torsemide (8mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Lisinopril (10mg Per Day)
  • Rabeprazole Sodium (10mg Per Day)


Thyroid Cancer
Adverse event was reported on Sep 13, 2011 by a Female taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 37 years of age, weighting 179.0 lb, Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: thyroid cancer.
Associated medications used:
  • Solostar
  • Metformin Hydrochloride (2 Tab Each After Breakfast And Supper)
  • Lantus
  • Lantus
  • Exenatide
  • Metformin Hydrochloride (After Breakfast)
  • Lantus
  • Metformin Hydrochloride (1 Tab Each After Breakfast And Supper)


Dermatitis Bullous
on Aug 15, 2011 Female from JAPAN , 66 years of age, weighting 105.8 lb, was diagnosed with and was treated with Olopatadine Hcl. Patient felt the following Olopatadine side effects: dermatitis bullous. Olopatadine Hcl dosage: N/A.
Multiple prescriptions taken:
  • Cozaar
  • Carvedilol
  • Mucosta


Thrombotic Cerebral Infarction, Decreased Appetite
on Jun 20, 2011 Female from JAPAN , 77 years of age, weighting 108.0 lb, was diagnosed with and was treated with Olopatadine Hcl. After Olopatadine was administered, patient encountered several Olopatadine side effects: thrombotic cerebral infarction, decreased appetite. Olopatadine Hcl dosage: 10 Mg, Qd.
Multiple concurrent drugs taken:
  • Victoza (0.6 Mg, Qd)
  • Victoza (0.9 Mg, Qd)
  • Amaryl (3 Mg, Qd)
  • Lasix (20 Mg, Qd)
  • Norvasc (5 Mg, Qd)
  • Sunrythm (75 Mg, Qd)
  • Digoxin (0.125 Mg, Qd)
  • Preran (1 Mg, Qd)
Patient was hospitalized.

Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased
Patient was taking Olopatadine. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: aspartate aminotransferase increased, hypersensitivity, alanine aminotransferase increased, eczema asteatotic, lymphocyte count decreased, blood amylase increased, rash, blood creatinine increased on Jun 14, 2011 from JAPAN Additional patient health information: Male , weighting 121.3 lb, . Olopatadine dosage: N/A.
Associated medications used:
  • Granisetron Hcl
  • Prednisolone
  • Levofloxacin
  • Famotidine
  • Bendamustine Hcl
  • Difluprednate
  • Brotizolam
  • Bendamustine Hcl
Patient was hospitalized.

Hepatitis Acute
Adverse event was reported on Jun 14, 2011 by a Male taking Olopatadine Hcl (Dosage: N/A) . Location: JAPAN , 22 years of age, Patient felt the following Olopatadine side effects: hepatitis acute.
Multiple prescriptions taken:
  • Allegra
Patient was hospitalized.

Product Formulation Issue, Bone Pain, Asthenia, Viral Infection
on Jul 14, 2010 Male from UNITED STATES , 54 years of age, was treated with Olopatadine. After Olopatadine was administered, patient encountered several Olopatadine side effects: product formulation issue, bone pain, asthenia, viral infection. Olopatadine dosage: N/A.
Multiple concurrent drugs taken:
  • Aspirin
  • Lasix
  • Prolastin-c (5900 Mg, Qw, Iv)
  • Prolastin
  • Albuterol
  • Xanax
  • Advair Diskus 100/50


White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis
on Feb 23, 2011 Male from JAPAN , 51 years of age, weighting 187.4 lb, was diagnosed with and was treated with Olopatadine Hydrochloride. Directly after, patient experienced the unwanted or unexpected Olopatadine side effects: white blood cell count increased, pain of skin, pyrexia, mobility decreased, arthralgia, hyperuricaemia, c-reactive protein increased, erythrodermic psoriasis. Olopatadine Hydrochloride dosage: N/A.
Associated medications used:
  • Lansoprazole
  • Enalapril Maleate
  • White Petroleum (Qs)
  • Carvedilol
  • Heparin (Qs)
  • Metenolone
  • Betamethasone Sodium Phosphate (Qs)
  • Ofloxacin (Qs)
Patient was hospitalized.

1 of 2 



PillPack: Pharmacy Simplified

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Olopatadine Side Effects



    Did You Have a Olopatadine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Olopatadine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative OLOPATADINE Names:OLOPATADI

    Active Ingredient: OLOPATADI

    More About Olopatadine

    Side Effects reported to FDA: 28

    Olopatadine safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 13

    Latest Olopatadine clinical trials

    Olopatadine Reviews

    No reviews, be a first to report a side effect via side effect reporting form